Omnicell, Inc. (OMCL)
43.12
-0.68
(-1.55%)
USD |
NASDAQ |
May 15, 16:00
43.12
0.00 (0.00%)
After-Hours: 20:00
Omnicell EPS Diluted (Quarterly) : 0.2472 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| American Shared Hospital Services | -0.091 |
| Delcath Systems, Inc. | -0.0297 |
| CytoSorbents Corp. | -0.0818 |
| Novo Integrated Sciences, Inc. | -- |
| Univec, Inc. | -0.0001 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 11.36M |
| Revenue (Quarterly) | 309.88M |
| Total Expenses (Quarterly) | 298.52M |
| Enterprise Value | 1.872B |
| Gross Profit Margin (Quarterly) | 45.30% |
| Profit Margin (Quarterly) | 3.67% |
| Earnings Yield | 1.02% |
| Operating Earnings Yield | 1.75% |
| Normalized Earnings Yield | 1.059 |